CVS Health expands direct-to-consumer weight management offering for GLP-1 access

A new partnership with Eli Lilly will add transparent pricing for Zepbound and Foundayo in the CVS Health app and could support same-day pickup at CVS pharmacies.

Summary

CVS Health is revamping its weight management program through a partnership with Eli Lilly, adding transparent pricing for Lilly's GLP-1 treatments Zepbound and Foundayo in the CVS Health app by early in the fourth quarter. The company said those treatments may also be available for same-day pickup at CVS pharmacies. The move builds on CVS Health's broader push to improve access, affordability, care and support for GLP-1 medications through its direct-to-consumer weight management offerings.

Terms & Concepts
  • GLP-1 treatments: Medicines that mimic a hormone involved in regulating appetite and blood sugar.
  • direct-to-consumer: A business model that offers products or services directly to patients rather than through traditional intermediaries.